FDA Inspection 1327360 - AstraZeneca Pharmaceuticals, LP - June 26, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AstraZeneca Pharmaceuticals, LP

Record Details

This FDA Inspection record concerns AstraZeneca Pharmaceuticals, LP, with an inspection on June 26, 2026, issued by the Philadelphia District Office, covering human drugs.

Company: AstraZeneca Pharmaceuticals, LP
Inspection Date: June 26, 2026
Product Type: Human Drugs
Office: Philadelphia District Office

Open in Dashboard

ID · 5b9f5d62-badb-435a-b322-32630163e2b4

Violation Codes1

21 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.